The Cancer Researcher
  • Home
  • About
  • The Cancer Researcher Podcast
  • #KeepResearchCurious
No Result
View All Result
  • Home
  • About
  • The Cancer Researcher Podcast
  • #KeepResearchCurious
No Result
View All Result
The Cancer Researcher
No Result
View All Result

Alberto Bardelli on what it’s like to ‘trend’ on Pubmed

June 26, 2018
Alberto Bardelli on what it’s like to ‘trend’ on Pubmed

PubMed is the leading search engine for biomedical literature, comprising more than 27 million citations for biomedical literature from MEDLINE, life science journals, and online books. 

PubMed has a page for “Trending articles” – PubMed records with a recent significant increase in views relative to baseline. Much like trending topics on social media, for an article to ‘trend’ on PubMed reflects a great surge of interest in the scientific community.


Trending: Inactivation of DNA repair triggers neoantigen generation and impairs tumour growth

We spoke to EACR President Elect, Alberto Bardelli, about his lab’s recent Nature paper “Inactivation of DNA repair triggers neoantigen generation and impairs tumour growth”, which was the number one trending article on PubMed for a significant period.


Why are the findings in the paper significant? (And how do you feel about it being the most popular paper on PubMed?)

The most exciting finding is the idea to turn an immune (cold) cancer into an immune (hot) one by triggering the emergence of neoantigens. If successful this strategy might, one day, lead to innovative therapies.

We were amazed to see that the paper has been continuously listed as the most Trending Article in PubMed, the main search engine for biomedical literature. PubMed contains over 27 million records (source: Wikipedia) and we are delighted that scientists worldwide found our results of interest and have shared the paper with others.

How long did it take from starting the research to it being published in Nature?

It took about three years, it was a long and complex journey as we sailed the uncharted waters of immunogenomics. Giovanni Germano,a young investigator and the first author of the study, worked relentlessly. The manuscript is largely the results of his dedication to science.

What is your lab working on now? (Is it directly based on the research in the paper, or have you moved on?)

The paper has opened up new avenues, and many lab members are following up on the Nature story. There are so many experiments we have designed and are presently ongoing! We are also engaging our clinical colleagues to see how we can best translate the new concepts in the clinical arena.


Find out more

Click here to access the Nature paper via PubMed: “Inactivation of DNA repair triggers neoantigen generation and impairs tumour growth.”

Professor Bardelli’s lab at the Candiolo Cancer Institute – IRCCS

Tags: interviewpublicationpublish or perish

Related Posts

“An exchange that has had a lasting impact on my research, my laboratory and my development as a cancer researcher”:  Peijin Jiang’s Travel Fellowship

“An exchange that has had a lasting impact on my research, my laboratory and my development as a cancer researcher”: Peijin Jiang’s Travel Fellowship

September 23, 2026

Peijin Jiang is a PhD student at the Vall d’Hebrón Institute of Oncology (VHIO), Spain, who received an EACR Travel Fellowship to visit and work at...

“Practical insights into leadership, communication, negotiation, and career development”: Inside the 2026 Women in Leadership Workshop

“Practical insights into leadership, communication, negotiation, and career development”: Inside the 2026 Women in Leadership Workshop

September 11, 2026

" provided practical insights into leadership, communication, negotiation, and career development that directly align with the challenges of establishing and leading an independent multidisciplinary research program....

Virtual conferences are no longer a compromise: What six years of data reveals

Virtual conferences are no longer a compromise: What six years of data reveals

October 6, 2026

When the EACR ran its first virtual conferences in 2020, it was a decision made to address the quickly evolving Covid-19 crisis. International travel was near...

The Cancer Researcher EACR logo

About Us

The Cancer Researcher is an online magazine for the cancer research community from the European Association for Cancer Research.

The EACR, a registered charity, is a global community for those working and studying in cancer research. Our mission is “The advancement of cancer research for the public benefit: from basic research to prevention, treatment and care.”

Advertisement Advertisement Advertisement
ADVERTISEMENT

RECENT POSTS

VIDEO | Transcriptome and repertoire profiling of infiltrating γδ T cells to decode tumor escape at single cell resolution
News

VIDEO | Transcriptome and repertoire profiling of infiltrating γδ T cells to decode tumor escape at single cell resolution

October 8, 2026
VIDEO | The Evolving ADC Landscape: From Monotherapies to Rational Combinations and Next-Generation Platforms
News

VIDEO | The Evolving ADC Landscape: From Monotherapies to Rational Combinations and Next-Generation Platforms

October 1, 2026
The Cancer Researcher

© 2025 EACR

Navigate site

  • About
  • Privacy
  • Main EACR website

Follow us

No Result
View All Result
  • Home
  • About
  • The Cancer Researcher Podcast
  • #KeepResearchCurious

© 2025 EACR